Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

54.20
Delayed Data
As of May 03
 +0.71 / +1.33%
Today’s Change
52.62
Today|||52-Week Range
72.31
-17.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues4.6B4.9B4.8B4.9B
 
 
 
 
 
Cost of Goods Sold1.7B1.7B1.7B1.7B
 
 
 
 
 
Depreciation And Amortization310.6M318.3M314.9M335.9M
 
 
 
 
 
 
Operating ExpensesGross Income2.6B2.8B2.8B2.9B
 
 
 
 
 
General Expenses1.4B1.5B1.5B1.7B
 
 
 
 
 
Research And Development307.8M380.4M360.8M447.2M
 
 
 
 
 
Total Operating Expenses3.4B3.6B3.5B3.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.2B1.3B1.3B1.2B
 
 
 
 
 
Extraordinary Credit32.4M6.9M125.9M--
 
 
 
 
Extraordinary Charge-632.3M-667.1M-1.0B-298.8M
 
 
 
 
 
Interest Expense On Debt53.8M33.5M113.0M47.1M
 
 
 
 
 
Equity In Earnings-8.3M5.9M-4.0M-114.3M
 
 
 
 
 
Other Expenses-2.8M8.9M-3.0M12.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income516.4M611.9M312.9M863.2M
 
 
 
 
 
Income Taxes-96.4M-86.7M-192.9M-249.6M
 
 
 
 
 
Minority Interest-1.9M---13.0M-2.0M
 
 
 
 
Preferred Dividend0.000.000.00-15.0M
 
 
Net Income413.5M531.1M103.0M501.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS851.0M849.0M851.0M866.0M
 
 
 
 
 
Shares To Calculate EPS Diluted859.0M859.0M862.0M875.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.48$0.63$0.12$0.56
 
 
 
 
 
EPS Diluted$0.48$0.62$0.12$0.55